Anaphylaxis is a rapid, potentially fatal allergic reaction with a global prevalence of 0.04%‐1.8%. Early intramuscular epinephrine administration is recommended. However, fear, pain, cost, or social barriers often delay treatment, leading to poor outcomes. To address these challenges, an intranasal (IN) epinephrine fo...
Manav Jain, P. Yamamoto, Amira Soliman et al.· Journal of clinical pharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.